Article: A Comprehensive Big Pharma M&A Analysis to 2012 - Surveying the Growth Rate Landscape in this Company-by-Company Evaluation.

Article: A Comprehensive Big Pharma M&A Analysis to 2012 - ...
Business Wire;  October 13, 2008 ;     700+ words ... ... addition of the "Big Pharma M&A Analysis ... Surveying the Growth Rate Landscape" report ... identified by the sales growth rate analysis Highlights of this title Big Pharma is facing a growth ... title * Evaluate Big Pharma companies ...

Article: Research and Markets: Learn How Roche Is Forecast To Achieve The ...
Business Wire;  November 16, 2006 ;     643 words ... ... forecast to achieve the strongest ethical sales growth rate among the Big pharma peer set over 2005-11 * Understand how Roche ... therapy areas of oncology and AIID, while much of Big Pharma remains entrenched in CV and CNS Topics Covered ...

Article: Financial and Strategic Analysis of the Sales Outlook for ...
Business Wire;  February 12, 2007 ;     700+ words ... ... Pharma dependency on top five, 10 and 20 products, 2011 Big Pharma molecule type analysis Big Pharma molecule type launch/core/expiry analysis Company ... dependency, 2005 Company by biologics dependency, 2011 Big Pharma growth rate by mole

Article: "Big Pharma' Turns To Biologics For Growth To 2010: ...
M2 Presswire;  June 5, 2006 ;     676 words ... ... Within the Big Pharma peer set, the revenue growth rate to 2010 forecast ... small molecule growth rate is depressed ... competition. Big Pharma has assumed ... the leading Big Pharma player within ... highest sales growth rate to 2010 within ...

Article: Research and Markets Adds Report: Big Pharma M&A ...
Health & Beauty Close-Up;  October 16, 2008 ;     588 words ... ... addition of the "Big Pharma M&A Analysis ... Surveying the Growth Rate Landscape" report ... plugging the sales growth rate gap and fulfilling ... evaluation of all Big Pharma-led M& ... acquirers sales growth rate between 2007 and ...

Article: Big Pharma companies are already looking for ...
M2 Presswire;  February 4, 2009 ;     700+ words ... ... adds new report: Big Pharma M&A Analysis ... Surveying the growth rate landscape http ... historic levels, Big Pharma companies must ... positive sales growth rate throughout the ... benefits to potential Big Pharma suitors. Moreover ...

Article: Big pharma ex-growth.
Investors Chronicle - magazine and web content;  December 17, 2007 ;     681 words ... ... threat from generic drugs. Big pharma is also extremely vulnerable ... the inherent strength of big pharma - massive cash flows. GlaxoSmithKline ... underscore the declining growth rate in the sector. But demand for big pharma's product will not wane ...